Red yeast rice: A new hypolipidemic drug

Life Sciences

Volumn 74, Issue 22, 2004, Pages 2675-2683

  Journoud, Mélanie ^a   Jones, Peter J H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cholesterol; Cholestin; Hypolipidemic drug; Red yeast rice

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTILIPEMIC AGENT; ATORVASTATIN; CHOLESTEROL; CHOLESTIN; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; MONASCUS PURPUREUS EXTRACT; PLANT EXTRACT; PRAVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; AORTA; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPEPSIA; EDEMA; ENDOTHELIUM CELL; FLATULENCE; HEADACHE; HEARTBURN; HUMAN; HYPOLIPEMIA; INSOMNIA; LIPID BLOOD LEVEL; MEDICINAL PLANT; MONASCUS PURPUREUS; MYALGIA; NAUSEA; NONHUMAN; RABBIT; RHABDOMYOLYSIS; SHORT SURVEY; THORAX PAIN; TREATMENT FAILURE; VISUAL IMPAIRMENT; VOMITING;

ANIMALS; ANTILIPEMIC AGENTS; BIOLOGICAL PRODUCTS; CHOLESTEROL; DIETARY SUPPLEMENTS; DRUGS, CHINESE HERBAL; HUMANS; HYPERCHOLESTEROLEMIA;

EID: 1642347600     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.10.018     Document Type: Short Survey

References (31)

1. Bliznakov E.G. More on the Chinese red-yeast-rice supplement and its cholesterol-lowering effect. American Journal of Clinical Nutrition. 71(1):2000;152-154.
2. Caron M.F., White C.M. Evaluation of the antihyperlipidemic properties of dietary supplements. Pharmacotherapy. 21(4):2001;481-487.
3. Havel R.J. Dietary supplement or drug? The case of cholestin. American Journal of Clinical Nutrition. 69(2):1999;175-176.
4. Heber D., Yip I., Ashley J.M., Elashoff D.A., Elashoff R.M., Go V.L. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. American Journal of Clinical Nutrition. 69(2):1999;231-236.
5. Keithley J.K., Swanson B., Sha B.E., Zeller J.M., Kessler H.A., Smith K.Y. A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia. Nutrition. 18(2):2002;201-204.
6. Li C., Zhu Y., Wang Y., Zhu J.-S., Chang J., Kritchevsky D. Monascus purpureus-fermented rice (red yeast rice): a natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutrition Research. 18(1):1998;71-81.
7. Ling W.H., Cheng Q.X., Ma J., Wang T. Red and black rice decrease atherosclerotic plaque formation and increase antioxidant status in rabbits. Journal of Nutrition. 131(5):2001;1421-1426.
8. Ling W.H., Wang L.L., Ma J. Supplementation of the black rice outer layer fraction to rabbits decreases atherosclerotic plaque formation and increases antioxidant status. Journal of Nutrition. 132(1):2002;20-26.
9. Ma J., Li Y., Ye Q., Li J., Hua Y., Ju D., Zhang D., Cooper R., Chang M. Constituents of red yeast rice, a traditional Chinese food and medicine. Journal of Agriculture and Food Chemistry. 48(11):2000;5220-5225.
10. Man R.Y., Lynn E.G., Cheung F., Tsang P.S., O K. Cholestin inhibits cholesterol synthesis and secretion in hepatic cells (hepG2). Molecular Cell Biochemistry. 233(1-2):2002;153-158.
11. Novartis. Lescol-lescol XL (fluvastatin sodium). 2002. URL, http://www.pharma.us.novartis.com/product/pi/pdf/Lescol.pdf; accessed 21.04.03.
12. Oki T., Masuda M., Kobayashi M., Nishiba Y., Furuta S., Suda I., Sato T. Polymeric procyanidins as radical-scavenging components in red-hulled rice. Journal of Agriculture and Food Chemistry. 50(26):2002;7524-7529.
13. Pfizer. Lipitor for lower cholesterol. 2002. URL, http://www.lipitor.com/ lipitor/default.asp; accessed 21.04.03.
14. Pharmanex. 2003. URL, http://www.pharmanex.com/; accessed 17.04.03.
15. Physicians' Desk Reference. 2003. Red yeast rice. URL, http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/red_0329.shtml; accessed 17.04.03.
16. Pronsky Z.M. Food Medication Interactions. 11th Edition:2000;Power and Moore's, Pennsylvania, USA. 333 pages.
17. Qin S., Zhang W., Qi P., Zhao M., Dong Z., Li Y., Xu X., Fang X., Fu L., Zhu J.-S., Chang J. Elderly patients with primary hyperlipidemia benefited from treatment with a monascus purpureus rice preparation: a placebo-controlled, double-blind clinical trial. The 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Poster presentations (P89), Orlando, Florida, USA, March 24-27 Circulation. vol. 99(8):1999;1123.
18. Rhyu M.R., Kim D.K., Kim H.Y., Kim B.K. Nitric oxide-mediated endothelium-dependent relaxation of rat thoracic aorta induced by aqueous extract of red rice fermented with monascus ruber. Journal of Ethnopharmacology. 70(1):2000;29-34.
19. Rippe J., Bonovich K., Colfer H., Davidson M., Dujovne C., Fried D., Greenspan M., King S., Karlsberg R., LaForce C., Litt M., McGhee J.R. A multicenter, self-controlled study of cholestin in subjects with elevated cholesterol. The 39th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Poster presentations (P88), Orlando, Florida, USA, March 24-27 Circulation. vol. 99(8):1999;1123.
20. Rx list. 2002. URL, http://www.rxlist.com/; accessed 17.04.03.
21. SoRelle R. Appeals court says Food and Drug Administration can regulate cholestin. Circulation. 102(7):2000;E9012-E9013.
22. University of British Columbia, The Department of Pharmacology and Therapeutics. Therapeutics initiative. Lipid lowering therapy. 1998. URL, http://www.ti.ubc.ca/PDF/24.PDF; accessed 17.04.03.
23. US Food and Drug Administration. Office of Regulatory Affairs. URL, http://www.fda.gov/ora/about/enf_story/ch4/cfsan4.htm; accessed 17.04.03.
24. US Food and Drug Administration. Office of Regulatory Affairs. The new drug development process: steps from test tube to new drug application review. URL, http://www.fda.gov/cder/handbook/develop.htm; accessed 21.04.03.
25. US Food and Drug Administration. Office of Regulatory Affairs. Center for Drug Evaluation and Research. Merck & co. 2002. Mevacor (lovastatin). URL, http://www.fda.gov/cder/foi/label/2002/19643s71lbl.pdf; accessed 21.04.03.
26. US Food and Drug Administration. Center for Drug Evaluation and Research. Bristol-Myers Squibb. 2001. Pravachol. URL, http://www.fda.gov/cder/foi/label/ 2001/19898s046lbl.pdf; accessed 21.04.03.
27. US Food and Drug Administration. Center for Drug Evaluation and Research. Merck & Co. 2001. Zocor (simvastatin). URL, http://www.fda.gov/cder/foi/ label/2001/19766s53lbl.pdf; accessed 21.04.03.
28. Wang J., Lu Z., Chi J., Wang W., Su M., Kou W., Yu P., Y'u L., Chen L., Zhu J.-S., Chang J. Multicenter clinical trial of the serum lipid-lowering effects of a monascus purpureus (red yeast) rice preparation from traditional Chinese medicine. Current Therapeutic Research. 58(12):1997;964-978.
29. Wigger-Alberti W., Bauer A., Hipler U.C., Elsner P. Anaphylaxis due to monascus purpureus-fermented rice (red yeast rice). Allergy. 54(12):1999;1330-1331.
30. Xia M., Ling W.H., Ma J., Kitts D.D., Zawistowski J. Supplementation of diets with the black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein E deficient mice. Journal of Nutrition. 133:2003;744-751.
31. Yu J.N., Cunningham J.A., Rosenberg Thouin S., Gurvich T., Liu D. Hyperlipidemia. Primary Care. 27(3):2000;541-587.